NURIX THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.36 USD | 0.00% |
|
-9.05% | +19.77% |
| 04-12 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
| 04-12 | Sector Update: Health Care | MT |
Chart calendar Nurix Therapeutics, Inc.
0a127d4897c4f76e.jz9bKbpfVd3ZcU-ADr8PJ1EXRXYR2taiBdAjeE-TK0Y.xV0aRsAsJ-69FwvtRI49bhpRfThHkLTrRqdmIB7wcyXeeRFo8iwliboZOA~f7e5271a1e7be6dbcb3bd7fc554cde9e
Upcoming events on Nurix Therapeutics, Inc.
Past events on Nurix Therapeutics, Inc.
| 16/04/2024 | Piper Sandler Spring Biopharma Symposium |
| 16/04/2024 18:00 | Stifel Virtual Targeted Oncology Days Conference |
| 10/04/2024 12:00 | Q1 2024 Earnings Release |
| 09/04/2024 18:15 | American Association for Cancer Research Meeting |
| 08/04/2024 16:00 | Needham Healthcare Conference |
| 06/04/2024 00:45 | American Association for Cancer Research Meeting |
| 13/03/2024 20:05 | Barclays Global Healthcare Conference - Fireside Chat |
| 11/03/2024 | Leerink Partners Global Biopharma Conference - One-On-One |
| 15/02/2024 21:00 | Q4 2023 Earnings Release |
| 08/01/2024 23:00 | JPMorgan Healthcare Conference |
| 12/12/2023 04:30 | Bruton Tyrosine Kinase Phase1 Trial Call |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Emma Searle |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Alexey Danilov |
| 11/12/2023 02:00 | American Society of Hematology Meeting - Graham P. Collins |
| 29/11/2023 20:00 | Piper Sandler Healthcare Conference |
| 14/11/2023 21:45 | Stifel Healthcare Conference |
| 12/10/2023 21:01 | Q3 2023 Earnings Release |
| 04/10/2023 19:45 | RBC Antibody Drug Conjugate Day |
| 12/09/2023 17:15 | Baird Global Healthcare Conference |
| 07/09/2023 20:00 | Wells Fargo Healthcare Conference |
Annual results
| Fiscal Period | November | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 31,1 | 17,8 14,0 26.89% | 29,8 35,2 -15.45% | 38,6 47,9 -19.42% | 77,0 94,1 -18.16% | 71,3 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -62,8 -80,4 21.93% | -115 -112 -2.76% | -179 -160 -11.83% | -148 -111 -32.61% | -152 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -65,0 -67,5 3.76% | -118 -112 -5.61% | -184 -176 -4.34% | -155 -139 -11.68% | -183 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -63,8 -65,9 3.21% | -117 -111 -5.67% | -180 -175 -3.04% | -144 -128 -12.87% | -171 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -43,2 -50,5 14.38% | -117 -111 -5.73% | -180 -176 -2.76% | -144 -126 -14.43% | -171 |
|
EPS USD | Released Forecast Spread | -2,20 | -2,76 -2,18 -26.36% | -2,73 -2,58 -5.75% | -3,71 -3,63 -2.29% | -2,65 -2,32 -14.29% | -2,98 |
| Announcement Date | 05/05/20 | 16/02/21 | 27/01/22 | 09/02/23 | 15/02/24 | - |
Quarterly results
| Fiscal Period | November | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,62 9,73 -1.09% | 11,4 10,5 8.88% | 10,8 12,1 -10.7% | 6,78 17,2 -60.5% | 12,7 11,0 15.76% | 30,7 26,2 16.92% | 18,5 18,0 2.88% | 15,2 34,1 -55.59% | 16,6 17,1 -2.93% | 21,8 | 17,5 | 16,8 | 16,9 | 16,9 |
|
EBIT Million USD | Released Forecast Spread | -42,7 -38,7 -10.38% | -45,7 -44,4 -3.02% | -46,7 -47,7 1.97% | -48,7 -43,4 -12.23% | -43,0 -46,5 7.55% | -26,8 -32,4 17.33% | -40,0 -40,7 1.77% | -45,3 -30,9 -46.77% | -45,2 -45,9 1.39% | -42,1 | -47,4 | -50,8 | -49,2 | -49,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -42,5 -38,5 -10.35% | -45,4 -44,2 -2.74% | -45,7 -47,6 3.91% | -46,7 -40,4 -15.51% | -40,7 -46,2 11.77% | -24,3 -31,8 23.67% | -37,0 -38,7 4.56% | -42,0 -28,6 -46.77% | -41,4 -44,1 6.09% | -39,2 | -44,4 | -47,7 | -48,2 | -48,4 |
|
Net income Million USD | Released Forecast Spread | -42,5 -38,5 -10.35% | -45,4 -44,3 -2.55% | -45,7 -47,8 4.32% | -46,7 -41,1 -13.76% | -40,7 -46,2 11.86% | -24,3 -31,2 22.26% | -37,0 -39,6 6.55% | -42,0 -23,8 -76% | -41,5 -44,1 5.89% | -39,2 | -44,5 | -47,7 | -48,2 | -48,4 |
|
EPS USD | Released Forecast Spread | -0,95 -0,89 -7.04% | -1,01 -0,99 -2.41% | -0,90 -0,97 6.87% | -0,86 -0,77 -12.1% | -0,75 -0,88 14.9% | -0,45 -0,59 23.51% | -0,68 -0,74 7.61% | -0,77 -0,44 -74.55% | -0,76 -0,80 4.87% | -0,70 | -0,75 | -0,77 | -0,78 | -0,78 |
| Announcement Date | 08/04/22 | 07/07/22 | 06/10/22 | 09/02/23 | 13/04/23 | 13/07/23 | 12/10/23 | 15/02/24 | 10/04/24 | - | - | - | - | - |
More events
Past sector events for Nurix Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NRIX Stock
- Calendar Nurix Therapeutics, Inc.
